TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations

MLA

Alexia Iasonos, et al. “TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.” Clinical Cancer Research, vol. 26, Apr. 2020, pp. 1624–32. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-19-3165.

APA

Alexia Iasonos, Maurizio Scaltriti, Debra A. Goldman, Alberto Bardelli, David M. Hyman, Yixiao Gong, Jaclyn F. Hechtman, Ritika Kundra, Emiliano Cocco, Ezra Y. Rosen, Alexander Drilon, Alison M. Schram, Ryma Benayed, Sophie Shifman, Barry S. Taylor, & James P. Solomon. (2020). TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations. Clinical Cancer Research, 26, 1624–1632. https://doi.org/10.1158/1078-0432.ccr-19-3165

Chicago

Alexia Iasonos, Maurizio Scaltriti, Debra A. Goldman, Alberto Bardelli, David M. Hyman, Yixiao Gong, Jaclyn F. Hechtman, et al. 2020. “TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.” Clinical Cancer Research 26 (April): 1624–32. doi:10.1158/1078-0432.ccr-19-3165.